[{"orgOrder":0,"company":"Eris Pharmaceuticals","sponsor":"Biocon","pharmaFlowCategory":"D","therapeuticArea":"Cardiology\/Vascular Diseases","country":"INDIA","productType":"Other Small Molecule","year":"2024","type":"Collaboration","leadProduct":"Metoprolol Succinate","moa":"||Adrenergic-beta-1 receptor","graph1":"Cardiology\/Vascular Diseases","graph2":"Approved FDF","graph3":"Eris Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Cardiovascular Diseases","amount2New":0,"dosageForm":"Oral Tablet, Prolonged Release","sponsorNew":"Eris Pharmaceuticals \/ Eris Pharmaceuticals","highestDevelopmentStatusID":"15","companyTruncated":"Eris Pharmaceuticals \/ Eris Pharmaceuticals"},{"orgOrder":0,"company":"Eris Pharmaceuticals","sponsor":"Biocon","pharmaFlowCategory":"D","therapeuticArea":"Oncology","country":"INDIA","productType":"Other Small Molecule","year":"2023","type":"Divestment","leadProduct":"Everolimus","moa":"||kinase","graph1":"Oncology","graph2":"Approved FDF","graph3":"Eris Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Oncology","amount2New":0,"dosageForm":"Oral Tablet","sponsorNew":"Eris Pharmaceuticals \/ Eris Pharmaceuticals","highestDevelopmentStatusID":"15","companyTruncated":"Eris Pharmaceuticals \/ Eris Pharmaceuticals"},{"orgOrder":0,"company":"Eris Pharmaceuticals","sponsor":"Dr. Reddy's Laboratories","pharmaFlowCategory":"D","therapeuticArea":"Dermatology","country":"INDIA","productType":"Other Small Molecule","year":"2023","type":"Divestment","leadProduct":"Salicylic Acid","moa":"||COX-1","graph1":"Dermatology","graph2":"Approved FDF","graph3":"Eris Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Dermatology","amount2New":0,"dosageForm":"Topical Ointment","sponsorNew":"Eris Pharmaceuticals \/ Eris Pharmaceuticals","highestDevelopmentStatusID":"15","companyTruncated":"Eris Pharmaceuticals \/ Eris Pharmaceuticals"},{"orgOrder":0,"company":"Eris Pharmaceuticals","sponsor":"Glenmark Pharmaceuticals","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"INDIA","productType":"Other Small Molecule","year":"2023","type":"Divestment","leadProduct":"Inapplicable","moa":"||Cell membrane synthesis","graph1":"Infections and Infectious Diseases","graph2":"Approved FDF","graph3":"Eris Pharmaceuticals","amount2":0,"highestDevelopmentShortName":"Approved FDF","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Eris Pharmaceuticals \/ Eris Pharmaceuticals","highestDevelopmentStatusID":"15","companyTruncated":"Eris Pharmaceuticals \/ Eris Pharmaceuticals"}]